TY - JOUR
T1 - Digital measurement of mobility in pulmonary arterial hypertension: A structured review of an emerging area
AU - Robertson, Erin
AU - Naghavi, Nader
AU - Wipperman, Matthew F.
AU - Tuckwell, Katie
AU - Effendi, Muhammad
AU - Alaj, Rinol
AU - Urbanek, Jacek
AU - Lederer, David
AU - Fredenburgh, Laura
AU - Stuart, Samuel
PY - 2024
Y1 - 2024
N2 - This review examined literature that has examined mobility in pulmonary arterial hypertension (PAH) using digital technology. Specifically, the review focussed on: (a) digital mobility measurement in PAH; (b) commonly reported mobility outcomes in PAH; (c) PAH specific impact on mobility outcomes; and (d) recommendations concerning protocols for mobility measurement in PAH. PubMed, Scopus, and Medline databases were searched. Two independent reviewers screened articles that described objective measurement of mobility in PAH using digital technology. Twenty-one articles were screened, and 16 articles met the inclusion/exclusion criteria and were reviewed. Current methodologies for mobility measurement in PAH with digital technologies are discussed. In brief, the reviewed evidence demonstrated that there is a lack of standardisation across studies for instrumentation, outcomes, and interpretation in PAH. The validity and reliability of digital approaches were insufficiently reported in all studies. Future research is required to standardise digital mobility measurement and characterise mobility impairments in PAH across clinical and real-world settings. The reviewed evidence suggests that digital mobility outcomes may be useful clinical measures and may be impaired in PAH, but further research is required to accurately and robustly establish findings. Recommendations are provided for future studies that encompass comprehensive reporting, validation, and measurement.
AB - This review examined literature that has examined mobility in pulmonary arterial hypertension (PAH) using digital technology. Specifically, the review focussed on: (a) digital mobility measurement in PAH; (b) commonly reported mobility outcomes in PAH; (c) PAH specific impact on mobility outcomes; and (d) recommendations concerning protocols for mobility measurement in PAH. PubMed, Scopus, and Medline databases were searched. Two independent reviewers screened articles that described objective measurement of mobility in PAH using digital technology. Twenty-one articles were screened, and 16 articles met the inclusion/exclusion criteria and were reviewed. Current methodologies for mobility measurement in PAH with digital technologies are discussed. In brief, the reviewed evidence demonstrated that there is a lack of standardisation across studies for instrumentation, outcomes, and interpretation in PAH. The validity and reliability of digital approaches were insufficiently reported in all studies. Future research is required to standardise digital mobility measurement and characterise mobility impairments in PAH across clinical and real-world settings. The reviewed evidence suggests that digital mobility outcomes may be useful clinical measures and may be impaired in PAH, but further research is required to accurately and robustly establish findings. Recommendations are provided for future studies that encompass comprehensive reporting, validation, and measurement.
KW - pulmonary arterial hypertension
KW - digital health technology
KW - wearables
KW - gait
KW - inertial sensors
KW - physical activity
KW - Mobility
UR - http://www.scopus.com/inward/record.url?scp=85204289622&partnerID=8YFLogxK
U2 - 10.1177/20552076241277174
DO - 10.1177/20552076241277174
M3 - Review article
SN - 2055-2076
VL - 10
SP - 1
EP - 24
JO - Digital Health
JF - Digital Health
ER -